Key Drivers
- Strong Liquidity
- Persistent Losses
- High Leverage
AIAI Summary
NEOG's investment case has shifted to proving that Food Safety growth and operational initiatives can deliver durable free cash flow and deleveraging, but at ~18x EV/EBITDA after a 100% rally, investors should wait for October evidence of sustained margins and resolution of Animal Safety supply disruptions before adding exposure.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Liquidity
- •Persistent Losses
- •High Leverage
NEOG has strong liquidity and positive cash flow, but losses, heavy debt, high intangibles, and elevated valuation warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Higher highs
- •Breakout momentum
- •Overbought risk
NEOG's last-month uptrend and breakout above $12.15 remain bullish, but an RSI near 81 makes chasing $13.00 risky unless $12.55–$12.25 support holds.
Rapid rise to $13.00 has created short-term pullback risk
Sentiment & News
Key News Insights:
- •Share-price surge
- •Institutional buying
- •Strategy catalysts
Neogen's strong share momentum, institutional buying, and upcoming Investor Day/earnings catalysts support optimism, though debt and competition remain key risks.
Near-term sentiment is positive, but execution on growth and debt reduction will determine whether gains are sustained
Similar Companies in Healthcare
Other companies in the same sector with AI ratings